Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDVRG.L Regulatory News (DVRG)

  • There is currently no data for DVRG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cost reductions;delay to Ann. Report;New contract

5 Jun 2023 07:00

RNS Number : 5720B
Deepverge PLC
05 June 2023
 

5 June 2023

 

DeepVerge plc

 

("DeepVerge" or "the Company" or "the Group")

 

Further cost reductions; Possible delay to publication of Annual Report and Accounts; New £2.3m, four-year contract

 

DeepVerge (AIM: DVRG), the environmental and life science group of companies that develops and applies AI and IoT technology to analytical instruments for the analysis and identification of bacteria, virus and toxins, announces that: (i) it will be downsizing its Labskin, Skin Trust Club and Rinocloud business units as part of further measures to improve the financial position of the Group; (ii) it is possible that it will need to delay the announcement of its results for the year ended 31 December 2022 and publication of its Annual Report and Accounts for the same period; (iii) it is continuing to carefully manage its working capital position and to seek new financing opportunities and also consider the potential sale of one or more lines of its business; and (iv) it is pleased to announce a new manufacturing contract win. 

Downsizing of the Labskin, Skin Trust Club and Rinocloud business units

The Company's financial position is such that the Board has taken the decision to no longer support the ongoing costs of progressing the development of the Labskin, Skin Trust Club and associated elements of the Rinocloud businesses, whilst retaining the capacity required to continue supporting the Modern Water and Glanaco businesses. The Company is therefore downsizing these business units, with effect from 1 July 2023, which will involve the elimination of approximately twenty permanent employee and contract positions. A programme is now in progress to ensure an orderly downsizing process is conducted.  The Company remains proud of the patents and databases that have been developed to date and continues to explore out-licensing opportunities of this technology with companies engaged in the life-sciences industry.

Possibility of delay to the announcement of the results for the year ended 31 December 2022 and publication of the Annual Report

The possibility of delay is caused, inter alia, by the resignation of the Group's previous auditor, Jeffreys Henry LLP, as announced on 24 March 2023. Following a change of ownership and name, Jeffreys Henry LLP undertook a review of its capacity to undertake audit work, in conjunction with the Institute of Chartered Accountants in England and Wales which concluded that the firm did not have sufficient capacity to satisfy its regulatory requirements and as a result resigned as auditor to a number of quoted companies, including DeepVerge.

 

The resignation of Jeffreys Henry occurred just days before the audit of DeepVerge's accounts was due to start. Haysmacintyre LLP was subsequently appointed as the Company's auditor, however there is significant risk of there being insufficient time to ensure that the audit is completed by 30 June 2023.

If the Company is unable to publish its Annual Report and Accounts by 30 June 2023 in accordance with AIM Rule 19, then the trading in the Company's ordinary shares on AIM would be suspended from 7.30am on Monday 3 July 2023 until such Annual Report is published. Any such delay would be likely to be limited to a matter of weeks.

New Funding opportunities and potential sale of parts of the business

The Company announced (RNSs of 17 and 19 April 2023) that due to the phasing and timing of contract cashflows it was operating from a limited working capital position. The Company continues to explore a number of financing options including the raising of equity, debt or trade finance to improve the Group's financial position. The Company is also exploring the potential sale of one or more lines of business.

New Manufacturing Contract in Ireland

The Company is pleased to announce that its subsidiary, Glanaco Ltd., has won a new contract for the supply of customised environmental cleaning and monitoring equipment to an undisclosed customer within the EU. Under the terms of the deal the Company will lease this equipment to the customer across a four-year period commencing in the second half of 2023.

The overall revenue will amount to approximately £2.3 million and will be recognised across the coming four years.

Further updates will be given as appropriate.

 

DeepVerge plc

Nigel Burton, Interim CEO

+44 (0) 7785 234447

SPARK Advisory Partners Limited

(Nominated Adviser)

Neil Baldwin

+44 (0) 113 370 8974

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker/James Pope

+44 (0) 20 3657 0050

 

This announcement contains inside information as stipulated under the UK version of the Market Abuse Regulation No 596/2014 which is part of English Law by virtue of the European (Withdrawal) Act 2018, as amended. On publication of this announcement via a Regulatory Information Service, this information is considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSLFLLEDSEDM
Date   Source Headline
30th Sep 20224:35 pmRNSPrice Monitoring Extension
30th Sep 202211:06 amRNSSecond Price Monitoring Extn
30th Sep 202211:00 amRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results
13th Sep 20227:00 amRNSBlue Carbon Resilience project
5th Aug 20227:00 amRNSTrading Update
1st Aug 20227:00 amRNSModern Water secures £2.1m projects
20th Jul 20221:42 pmRNSResult of AGM
20th Jul 20227:00 amRNSDeepVerge to explore options for Labskin Division
19th Jul 20224:41 pmRNSSecond Price Monitoring Extn
19th Jul 20224:36 pmRNSPrice Monitoring Extension
18th Jul 20227:01 amRNSModern Water monitoring systems deal worth £1.4m
4th Jul 20227:00 amRNSSkin Trust Club - update
30th Jun 20227:00 amRNSModern Water Q2 orders exceed £3m, RPT
27th Jun 202211:50 amRNSNotice of AGM
23rd Jun 20227:12 amRNSFinal Results
13th Jun 20227:00 amRNSNotice of Final Results and Annual Report
1st Jun 20221:36 pmRNSSkin Trust Club wins Best New Disrupter Brand
30th May 20227:00 amRNSTesting Services Framework Ag with Abingdon Health
26th Apr 20227:00 amRNSDeepVerge presents at Global Group Investor Summit
19th Apr 20227:00 amRNSUpdate; Manuf'g Service Agreement with Microsaic
19th Apr 20227:00 amRNSHolding(s) in Company
29th Mar 20227:00 amRNSMoU with Abingdon Health for lateral flow tests
28th Mar 20227:00 amRNS1st UK Deployments of Microtox®PD in Wastewater
18th Mar 202211:05 amRNSSecond Price Monitoring Extn
18th Mar 202211:00 amRNSPrice Monitoring Extension
17th Mar 202210:59 amRNSDirector Dealing
17th Mar 20227:00 amRNSAcquisition; Loan Facility for global expansion
11th Mar 20229:05 amRNSSecond Price Monitoring Extn
11th Mar 20229:00 amRNSPrice Monitoring Extension
11th Mar 20227:00 amRNSDeepVerge Q1 production orders up 39% to £5m
21st Feb 20227:00 amRNS82% of Skin Trust Club members purchase via App
19th Jan 20227:00 amRNSMicrotoxPD detects 3 COVID variants of concern
17th Jan 202211:05 amRNSSecond Price Monitoring Extn
17th Jan 202211:00 amRNSPrice Monitoring Extension
11th Jan 20227:00 amRNSTrading Update
6th Jan 20227:00 amRNSMicrotox CTM installed ahead of Winter Olympics
13th Dec 20217:00 amRNSAmends to Agreement with Microsaic Systems; RPT
10th Dec 20219:00 amRNSPrice Monitoring Extension
10th Dec 20217:00 amRNSCompact Microtox® PD launch scheduled for Q1 2022
9th Dec 20214:41 pmRNSSecond Price Monitoring Extn
9th Dec 20214:36 pmRNSPrice Monitoring Extension
26th Nov 20217:00 amRNSRelated Party Transaction
11th Nov 20217:00 amRNSU.S. launch of Skin Trust Club at Beauty Connect
4th Nov 20218:00 amRNSPDMR Dealing
4th Nov 20217:00 amRNSGrant supports DeepVerge Centre of Excellence
3rd Nov 20217:00 amRNSConfirmation of Post-Offer Intention Statements
28th Oct 20217:00 amRNSMicrotox® PD installations as part of nat'l trial
21st Oct 20219:05 amRNSSecond Price Monitoring Extn
21st Oct 20219:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.